Your email was sent successfully. Check your inbox.

An error occurred while sending the email. Please try again.

Proceed reservation?

Export
  • 1
    Keywords: brain ; CANCER ; tumor ; CLASSIFICATION ; EPIDEMIOLOGY ; RISK ; SAMPLE ; SAMPLES ; meningioma ; TUMORS ; PATIENT ; RISK-FACTORS ; GROWTH-FACTOR RECEPTOR ; COMPARATIVE GENOMIC HYBRIDIZATION ; DIFFERENCE ; genetics ; etiology ; risk factors ; ACUTE LYMPHOBLASTIC-LEUKEMIA ; UNITED-STATES ; CENTRAL-NERVOUS-SYSTEM ; STATES ; molecular epidemiology ; molecular ; ONCOLOGY ; review ; BRAIN-TUMORS ; GLIOMA ; RECURSIVE PARTITIONING ANALYSIS ; interaction ; brain tumors ; REGULATORY T-CELLS ; methods ; SUBTYPES ; TECHNOLOGY ; USA ; RISK-FACTOR ; ATOMIC-BOMB SURVIVORS ; pediatric ; OCCUPATIONAL RISK-FACTORS ; MOBILE PHONE USE ; interactions ; CONSORTIUM ; INVESTIGATORS ; MALIGNANT GLIOMA PATIENTS
    Abstract: Epidemiologists in the Brain Tumor Epidemiology Consortium (BTEC) have prioritized areas for further research. Although many risk factors have been examined over the past several decades, there are few consistent findings, possibly because of small sample sizes in individual studies and differences between studies in patients, tumor types, and methods of classification. Individual studies generally have lacked samples of sufficient size to examine interactions. A major priority based on available evidence and technologies includes expanding research in genetics and molecular epidemiology of brain tumors. BTEC has taken an active role in Promoting understudied groups, such as pediatric brain tumors; the etiology of rare glioma subtypes, such as oligodendroglioma; and meningioma, which, although it is not uncommon, has only recently, been registered systematically in the United States. There also is a pressing need for more researchers, especially junior investigators, to study brain tumor epidemiology. However, relatively poor funding for brain tumor research has made it difficult to encourage careers in this area. In this report, BTEC epidemiologists reviewed the groups Consensus oil the Current state of scientific findings, and they present a consensus oil research priorities to identify which important areas the science should move to address
    Type of Publication: Journal article published
    PubMed ID: 18798534
    Signatur Availability
    BibTip Others were also interested in ...
  • 2
    Keywords: CANCER ; THERAPY ; INFORMATION ; COHORT ; DISEASE ; incidence ; RISK ; RISK-FACTORS ; BREAST ; BREAST-CANCER ; DESIGN ; AGE ; WOMEN ; PROSPECTIVE COHORT ; smoking ; cancer risk ; UNITED-STATES ; ALCOHOL ; ALCOHOL-CONSUMPTION ; CONSUMPTION ; BIRTH COHORT ; POSTMENOPAUSAL WOMEN ; MASS INDEX ; ORAL-CONTRACEPTIVE USE ; REQUIRING PROLONGED OBSERVATION ; METAANALYSIS ; HORMONAL FACTORS ; ANTHROPOMETRIC MEASURES ; EPITHELIAL OVARIAN
    Abstract: BACKGROUND: Only about half the studies that have collected information on the relevance of women's height and body mass index to their risk of developing ovarian cancer have published their results, and findings are inconsistent. Here, we bring together the worldwide evidence, published and unpublished, and describe these relationships. METHODS AND FINDINGS: Individual data on 25,157 women with ovarian cancer and 81,311 women without ovarian cancer from 47 epidemiological studies were collected, checked, and analysed centrally. Adjusted relative risks of ovarian cancer were calculated, by height and by body mass index. Ovarian cancer risk increased significantly with height and with body mass index, except in studies using hospital controls. For other study designs, the relative risk of ovarian cancer per 5 cm increase in height was 1.07 (95% confidence interval [CI], 1.05-1.09; p〈0.001); this relationship did not vary significantly by women's age, year of birth, education, age at menarche, parity, menopausal status, smoking, alcohol consumption, having had a hysterectomy, having first degree relatives with ovarian or breast cancer, use of oral contraceptives, or use of menopausal hormone therapy. For body mass index, there was significant heterogeneity (p〈0.001) in the findings between ever-users and never-users of menopausal hormone therapy, but not by the 11 other factors listed above. The relative risk for ovarian cancer per 5 kg/m(2) increase in body mass index was 1.10 (95% CI, 1.07-1.13; p〈0.001) in never-users and 0.95 (95% CI, 0.92-0.99; p = 0.02) in ever-users of hormone therapy. CONCLUSIONS: Ovarian cancer is associated with height and, among never-users of hormone therapy, with body mass index. In high-income countries, both height and body mass index have been increasing in birth cohorts now developing the disease. If all other relevant factors had remained constant, then these increases in height and weight would be associated with a 3% increase in ovarian cancer incidence per decade. Please see later in the article for the Editors' Summary.
    Type of Publication: Journal article published
    PubMed ID: 22606070
    Signatur Availability
    BibTip Others were also interested in ...
  • 3
    Keywords: CANCER ; Germany ; COMMON ; INFORMATION ; EXPOSURE ; HISTORY ; POPULATION ; RISK ; RISKS ; meningioma ; TISSUE ; IMPACT ; RISK-FACTORS ; TISSUES ; tumour ; FREQUENCY ; FIELD ; FREQUENCIES ; HEALTH ; DESIGN ; NUMBER ; risk factors ; COUNTRIES ; SWEDEN ; FRANCE ; NETHERLANDS ; case-control studies ; study design ; AUSTRALIA ; FINLAND ; case control study ; case-control study ; RE ; BRAIN-TUMORS ; INCREASE ; GLIOMA ; RECALL ; GLAND ; case control studies ; methods ; CELLULAR-TELEPHONE USE ; RISK-FACTOR ; CANCER-RISK ; E ; carcinogenic ; INCREASES ; case control ; acoustic neuroma ; brain tumours ; mobile phone ; MOBILE PHONE USE ; SETUP ; acoustic neurinoma ; benign tumours ; case-control ; CORDLESS TELEPHONES ; FIELDS ; mobile phones ; parotid gland tumours ; SELECTION BIAS
    Abstract: The very rapid worldwide increase in mobile phone use in the last decade has generated considerable interest in the possible health effects of exposure to radio frequency (RF) fields. A multinational case-control study, INTERPHONE, was set-up to investigate whether mobile phone use increases the risk of cancer and, more specifically, whether the RF fields emitted by mobile phones are carcinogenic. The study focused on tumours arising in the tissues most exposed to RF fields from mobile phones: glioma, meningioma, acoustic neurinoma and parotid gland tumours. In addition to a detailed history of mobile phone use, information was collected on a number of known and potential risk factors for these tumours. The study was conducted in 13 countries. Australia, Canada, Denmark, Finland, France, Germany, Israel, Italy, Japan, New Zealand, Norway, Sweden, and the UK using a common core protocol. This paper describes the study design and methods and the main characteristics of the study population. INTERPHONE is the largest case-control study to date investigating risks related to mobile phone use and to other potential risk factors for the tumours of interest and includes 2,765 glioma, 2,425 meningioma, 1,121 acoustic neurinoma, 109 malignant parotid gland tumour cases and 7,658 controls. Particular attention was paid to estimating the amount and direction of potential recall and participation biases and their impact on the study results
    Type of Publication: Journal article published
    PubMed ID: 17636416
    Signatur Availability
    BibTip Others were also interested in ...
  • 4
    Keywords: CANCER ; EPIDEMIOLOGY ; EXPOSURE ; RISK ; RISKS ; HEALTH ; BRAIN-TUMORS ; RECALL ; brain tumour ; vestibular schwannoma ; CANCER-RISK ; acoustic neuroma ; CORDLESS TELEPHONES ; mobile phones ; SELECTION BIAS ; PHONE USE ; CELLULAR TELEPHONES ; LOUD NOISE ; Radiofrequency electromagnetic fields
    Abstract: Background: The rapid increase in mobile telephone use has generated concern about possible health risks of radiofrequency electromagnetic fields from these devices. Methods: A case-control study of 1105 patients with newly diagnosed acoustic neuroma (vestibular schwannoma) and 2145 controls was conducted in 13 countries using a common protocol. Past mobile phone use was assessed by personal interview. In the primary analysis, exposure time was censored at one year before the reference date (date of diagnosis for cases and date of diagnosis of the matched case for controls); analyses censoring exposure at five years before the reference date were also done to allow for a possible longer latent period. Results: The odds ratio (OR) of acoustic neuroma with ever having been a regular mobile phone user was 0.85 (95% confidence interval 0.69-1.04). The OR for 〉= 10 years after first regular mobile phone use was 0.76 (0.52-1.11). There was no trend of increasing ORs with increasing cumulative call time or cumulative number of calls, with the lowest OR (0.48 (0.30-0.78)) observed in the 9th decile of cumulative call time. In the 10th decile (〉= 1640 h) of cumulative call time, the OR was 1.32 (0.88-1.97); there were, however, implausible values of reported use in those with 〉= 1640 h of accumulated mobile phone use. With censoring at 5 years before the reference date the OR for 〉= 10 years after first regular mobile phone use was 0.83 (0.58-1.19) and for 〉= 1640 h of cumulative call time it was 2.79(1.51-5.16). but again with no trend in the lower nine deciles and with the lowest OR in the 9th decile. In general, ORs were not greater in subjects who reported usual phone use on the same side of the head as their tumour than in those who reported it on the opposite side, but it was greater in those in the 10th decile of cumulative hours of use. Conclusions: There was no increase in risk of acoustic neuroma with ever regular use of a mobile phone or for users who began regular use 10 years or more before the reference date. Elevated odds ratios observed at the highest level of cumulative call time could be due to chance, reporting bias or a causal effect. As acoustic neuroma is usually a slowly growing tumour, the interval between introduction of mobile phones and occurrence of the tumour might have been too short to observe an effect, if there is one.
    Type of Publication: Journal article published
    PubMed ID: 21862434
    Signatur Availability
    BibTip Others were also interested in ...
  • 5
    Keywords: CANCER ; EPIDEMIOLOGY ; CARCINOGENS ; CENTRAL-NERVOUS-SYSTEM ; GLIOMAS ; MATRIX ; CHILDHOOD ; FARMERS ; CHEMICALS ; ADULT BRAIN-TUMORS
    Abstract: OBJECTIVE: To examine associations between occupational exposure to selected organic solvents and meningioma. METHODOLOGY: A multicentre case-control study conducted in seven countries, including 1906 cases and 5565 controls. Occupational exposure to selected classes of organic solvents (aliphatic and alicyclic hydrocarbons, aromatic hydrocarbons, chlorinated hydrocarbons and 'other' organic solvents) or seven specific solvents (benzene, toluene, trichloroethylene, perchloroethylene, 1,1,1-trichloroethylene, methylene chloride and gasoline) was assessed using lifetime occupational histories and a modified version of the FINJEM job-exposure matrix (INTEROCC-JEM). Study participants were classified as 'exposed' when they had worked in an occupation for at least 1 year, with a 5-year lag, in which the estimated prevalence of exposure was 25% or greater in the INTEROCC-JEM. Associations between meningioma and each of the solvent exposures were estimated using conditional logistic regression, adjusting for potential confounders. RESULTS: A total of 6.5% of study participants were ever exposed to 'any' solvent, with a somewhat greater proportion of controls (7%) ever exposed compared with cases (5%), but only one case was ever exposed to any chlorinated hydrocarbon (1,1,1-trichloroethane). No association was observed between any of the organic solvents and meningioma, in either men or women, and no dose-response relationships were observed in internal analyses using either exposure duration or cumulative exposure. DISCUSSION: We found no evidence that occupational exposure to these organic solvents is associated with meningioma.
    Type of Publication: Journal article published
    PubMed ID: 24474387
    Signatur Availability
    BibTip Others were also interested in ...
Close ⊗
This website uses cookies and the analysis tool Matomo. More information can be found here...